Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display

被引:176
作者
Payne, AS
Ishii, K
Kacir, S
Lin, CY
Li, H
Hanakawa, Y
Tsunoda, K
Amagai, M
Stanley, JR
Siege, DL
机构
[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan
关键词
D O I
10.1172/JCI200524185
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pemphigus is a life-threatening blistering disorder of the skin and mucous membranes caused by pathogenic autoantibodies to desmosomal adhesion proteins desmoglein 3 (Dsg3) and Dsg1. Mechanisms of antibody pathogenicity are difficult to characterize using polyclonal patient sera. Using antibody phage display, we have isolated repertoires of human anti-Dsg mAbs as single-chain variable-region fragments (scFvs) from a patient with active mucocutaneous pemphigus vulgaris. ScFv mAbs demonstrated binding to Dsg3 or Dsg1 alone, or both Dsg3 and Dsg1. Inhibition ELISA showed that the epitopes defined by these scFvs are blocked by autoantibodies from multiple pemphigus patients. Injection of scFvs into neonatal mice identified 2 pathogenic scFvs that caused blisters histologically similar to those observed in pemphigus patients. Similarly, these 2 scFvs, but not others, induced cell sheet dissociation of cultured human keratinocytes, indicating that both pathogenic and nonpathogenic antibodies were isolated. Genetic analysis of these mAbs showed restricted patterns of heavy and light chain gene usage, which were distinct for scFvs with different desmoglein-binding specificities. Detailed characterization of these pemphigus mAbs should lead to a better understanding of the immunopathogenesis of disease and to more specifically targeted therapeutic approaches.
引用
收藏
页码:888 / 899
页数:12
相关论文
共 53 条
[1]  
ADDERSON EE, 1991, J IMMUNOL, V147, P1667
[2]   Anti-idiotype antibodies neutralize in vivo the blistering effect of Pemphigus foliaceus IgG [J].
Alvarado-Flores, E ;
Avalos-Díaz, E ;
Díaz, LA ;
Herrera-Esparza, R .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 53 (03) :254-258
[3]   CONFORMATIONAL EPITOPES OF PEMPHIGUS ANTIGENS (DSG1 AND DSG3) ARE CALCIUM-DEPENDENT AND GLYCOSYLATION INDEPENDENT [J].
AMAGAI, M ;
ISHII, K ;
HASHIMOTO, T ;
GAMOU, S ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (02) :243-247
[4]   Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1 [J].
Amagai, M ;
Matsuyoshi, N ;
Wang, ZH ;
Andl, C ;
Stanley, JR .
NATURE MEDICINE, 2000, 6 (11) :1275-1277
[5]   ANTIGEN-SPECIFIC IMMUNOADSORPTION OF PATHOGENIC AUTOANTIBODIES IN PEMPHIGUS FOLIACEUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
GREEN, KJ ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (06) :895-901
[6]   Use of autoantigen-knockout mice in developing an active disease model for pemphigus [J].
Amagai, M ;
Tsunoda, K ;
Suzuki, H ;
Nishifuji, K ;
Koyasu, S ;
Nishikawa, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (05) :625-631
[7]   The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile [J].
Amagai, M ;
Tsunoda, K ;
Zillikens, D ;
Nagai, T ;
Nishikawa, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (02) :167-170
[8]   AUTOANTIBODIES AGAINST THE AMINO-TERMINAL CADHERIN-LIKE BINDING DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN ARE PATHOGENIC [J].
AMAGAI, M ;
KARPATI, S ;
PRUSSICK, R ;
KLAUSKOVTUN, V ;
STANLEY, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :919-926
[9]   ABSORPTION OF PATHOGENIC AUTOANTIBODIES BY THE EXTRACELLULAR DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN (DSG3) PRODUCED BY BACULOVIRUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :59-67
[10]  
Barbas C. F., 2001, PHAGE DISPLAY LAB MA